PCOS, Now Recognised as PMOS: The Signs Most Often Missed in Your Twenties and Thirties

Highlights

Half of all women with PMOS are undiagnosed. The condition is common, affecting up to one in ten women of reproductive age, and yet around half of those who have it do not know.
The symptoms are easy to dismiss individually. Irregular periods, persistent acne, difficulty losing weight, mood changes, and fatigue are each easy to explain away. Together, they tell a different story.
You do not need to have cysts to have PMOS. Despite the name, polycystic ovaries are not required for diagnosis. Many women are told they are clear when they are not.
Diagnosis in your twenties and thirties changes what comes next. Earlier identification means earlier treatment of insulin resistance, hormonal imbalance, and long-term metabolic risk, before the consequences compound.

Your periods have always been a bit unpredictable. Your skin has never quite settled. You have been trying to lose weight and it will not shift the way it used to. You are tired in a way that sleep does not fix.

You may have heard it called PCOS. It is now being renamed PMOS. The condition is the same. The understanding of it has deepened.

Separately, each of these feels like something to manage. Together, they may be telling you something.

PMOS (Polyendocrine Metabolic Ovarian Syndrome) affects an estimated 5 to 18 per cent of women of reproductive age worldwide. Around half of those women are undiagnosed. Not because the signs are invisible, but because they are each so easy to explain away on their own, and because a condition that presents so differently in different women is genuinely difficult to pin down without the right investigation.

The average delay between first symptoms and diagnosis remains five to ten years. For many women, that delay means years of managing symptoms without understanding their cause, and years of metabolic risk accumulating without treatment.

At Menovivre, we see women at every stage of this journey: newly diagnosed, long-suspected, or still wondering. This article explains what PMOS actually is, the signs most commonly missed in the twenties and thirties, why diagnosis is so often delayed, and what proper assessment looks like.

Quick Answer

PCOS, now formally recognised by many specialists as PMOS (Polyendocrine Metabolic Ovarian Syndrome), is one of the most common hormonal conditions in women of reproductive age, affecting an estimated 5 to 18 per cent globally. The signs most often missed in the twenties and thirties include irregular or absent periods, persistent acne beyond teenage years, unexplained weight gain or difficulty losing weight despite effort, excess hair growth on the face or body, thinning scalp hair, low mood and anxiety, chronic fatigue, and difficulty conceiving. Because each symptom is easy to attribute to something else, the average diagnostic delay remains five to ten years. A proper hormonal assessment is the only reliable way to confirm or rule it out.

What PCOS Is, and Why It Is Now Being Called PMOS

PMOS, or Polyendocrine Metabolic Ovarian Syndrome, is a hormonal condition characterised by three features: irregular or absent ovulation, elevated androgens (male hormones including testosterone), and, in some cases, polycystic-appearing ovaries on ultrasound. To be diagnosed under the most widely used criteria (the Rotterdam criteria), a woman needs to meet at least two of these three. Polycystic ovaries alone, without hormonal disruption or irregular cycles, are not sufficient.

This is one of the most important things to understand about PMOS, and one of the most common sources of confusion: you do not need to have cysts to have it. Many women are told their ovaries look clear on ultrasound and conclude they are in the clear. That is not how the diagnosis works.

A Name Change Worth Knowing About

You may start to see the term PMOS appearing more frequently, both in clinical literature and in conversations with specialists. PMOS stands for Polyendocrine Metabolic Ovarian Syndrome, and it is the name a consensus of international specialists proposed in 2025 to replace PCOS.

The reason for the rename is not cosmetic. Calling it polycystic ovary syndrome implied that cysts on the ovaries were the defining feature, when the condition is more accurately understood as a metabolic and endocrine disorder that happens to affect the ovaries. PMOS better reflects what the condition actually is and how it should be managed.

Why PMOS Takes So Long to Diagnose

The diagnostic delay is not primarily a failure of medicine. It is a failure of how the condition presents.

PMOS does not announce itself with one clear, unmistakable symptom. It layers several symptoms that individually seem unremarkable: periods that are a bit irregular, skin that is a bit difficult, energy that is a bit low, weight that is a bit resistant. None of these, on their own, sends a woman to a specialist. And in a brief GP consultation, no single symptom necessarily triggers a hormonal workup.

Research published in PubMed confirms that around half of women who meet the Rotterdam criteria for PMOS are undiagnosed until they actively seek investigation, most commonly prompted by fertility difficulties. Women whose primary presentation is metabolic or psychological rather than reproductive are particularly likely to be missed.

This is the pattern we see. Women who have been treating acne with topical products for a decade. Women who have been told their fatigue is stress. Women who have been trying to lose weight for years and have been given dietary advice that does not account for insulin resistance. The common thread is that the symptoms were addressed in isolation, and the underlying hormonal picture was never investigated.

The Eight Signs Most Often Missed

Sign	Why it is often missed
Irregular or absent periods	Often explained as stress, overexercise, or simply how you are. A cycle that is unpredictable or absent for months is a hormonal signal.
Persistent acne after teenage years	Adult acne along the jawline, chin, and neck is a classic androgen excess presentation. Often treated with topical products for years without investigating the hormonal root.
Unexplained weight gain	Particularly around the abdomen, and resistant to typical dietary effort. Driven by insulin resistance rather than caloric excess.
Excess facial or body hair	Growth on the chin, upper lip, jawline, chest, or stomach. Caused by elevated androgens. Often managed cosmetically rather than clinically.
Scalp hair thinning	A male-pattern thinning at the crown or temples. Less recognised than facial hair growth but equally common in androgen excess.
Low mood and anxiety	Depression and anxiety occur in up to 60 per cent of women with PMOS. Routinely attributed to life circumstances rather than hormonal imbalance.
Chronic fatigue	Driven by insulin resistance and disrupted sleep. Not resolved by rest. Often dismissed as burnout or poor sleep habits.
Difficulty conceiving	PMOS accounts for up to 20 per cent of female fertility problems. For some women, this is the first sign that prompts investigation.

The Metabolic Core of PMOS: Why Insulin Resistance Is the Piece Most Often Left Out

PMOS, or as it is increasingly known, PMOS, is frequently discussed as a reproductive condition. The less often told part of the story is metabolic.

Insulin resistance is present in 60 to 80 per cent of women with PMOS, regardless of body weight. When cells respond poorly to insulin, the pancreas compensates by producing more of it. Elevated insulin directly stimulates the ovaries to produce excess androgens, which disrupts ovulation, drives acne and excess hair growth, and makes fat storage around the abdomen particularly resistant to change.

The cycle is self-reinforcing: insulin resistance worsens androgen excess, and androgen excess worsens insulin resistance. Breaking it requires addressing the metabolic dimension directly, not just managing individual symptoms.

A standard blood glucose test will often miss insulin resistance in its early stages, because glucose can remain normal while insulin is already elevated. A fasting insulin test, run alongside glucose, gives a much clearer picture. If you have not had this tested and you suspect PMOS, it is worth asking for it specifically.

What a Proper Assessment Looks Like

A thorough PMOS assessment is not complicated, but it needs to cover the right ground.

A full hormonal blood panel: LH, FSH, testosterone (total and free), DHEAS, SHBG, prolactin, and thyroid function, to rule out conditions that mimic PMOS.
A metabolic panel: fasting insulin and glucose, HbA1c, and a full lipid profile, to assess the metabolic dimension of the condition.
A detailed menstrual history: cycle length, regularity, and any changes over time.
A pelvic ultrasound: to assess ovarian morphology, noting that this alone is not diagnostic.
A body composition assessment: to understand the relationship between weight distribution and insulin resistance.

The result of this assessment is not just a diagnosis. It is a clinical picture that tells you what is driving your specific presentation, which in PMOS varies significantly from woman to woman, and what a personalised approach to treatment looks like.

What Treatment Actually Involves

PMOS cannot be cured, but it can be managed effectively, and the earlier that management begins, the better the long-term metabolic and reproductive outcomes.

The foundation of treatment is lifestyle: nutrition that targets insulin resistance, consistent movement that builds muscle and improves insulin sensitivity, and sleep that supports hormonal regulation. These are not peripheral suggestions. They are the most evidence-supported interventions for improving insulin sensitivity and reducing androgen levels.

Medication adds another layer where appropriate. Metformin, which improves insulin sensitivity, is widely used. The combined oral contraceptive pill can regulate cycles and reduce androgen effects on the skin. Inositol, specifically myo-inositol and D-chiro-inositol, has an emerging evidence base for improving insulin sensitivity and ovarian function in PMOS.

For women whose primary concern is fertility, a joined-up approach that addresses insulin resistance, supports ovulation, and considers timing and conception readiness is more effective than addressing fertility in isolation. Our Fertility Optimisation Programme at Menovivre is built around exactly this: assessing the full hormonal and metabolic picture before making any fertility recommendations.

If Any of This Sounds Familiar, It Is Worth Investigating

PMOS is not a dramatic condition. It does not arrive with an obvious crisis. It arrives quietly, in the accumulation of symptoms that are easy to live around but that gradually shape your energy, your skin, your weight, and your sense of yourself.

If you have been managing these things individually without ever having had a proper hormonal assessment, that assessment is a reasonable and worthwhile next step. You do not need a referral. You do not need to have all the pieces already joined up. You just need to ask the question.

You can request an appointment at Menovivre without a GP referral. Our clinical team will take a thorough history, run the appropriate investigations, and give you a clear picture of what is happening and what to do about it.

Frequently Asked Questions

Q1: Can you have PMOS without cysts on your ovaries?

A: Yes. This is one of the most widely misunderstood points about PMOS. Under the Rotterdam criteria, the most commonly used diagnostic framework, a woman needs to meet only two of three criteria: irregular or absent ovulation, elevated androgens, and polycystic-appearing ovaries on ultrasound. Polycystic ovaries are not required for diagnosis. Many women with confirmed PMOS have normal-looking ovaries on scan.

Q2. Can PMOS be cured?

A: No, but it can be managed effectively. The symptoms of PMOS, including irregular periods, androgen excess, insulin resistance, and fertility difficulty, all respond to the right combination of lifestyle, medication, and hormonal support. For many women, well-managed PMOS has a minimal impact on daily life and long-term health outcomes. For women who reach menopause, the condition often changes significantly, as estrogen decline reduces some of the hormonal drivers.

Q3. Does PMOS always cause weight gain?

A: Not always, but insulin resistance, which is present in the majority of women with PMOS regardless of weight, makes weight management harder than it would otherwise be. Women with PMOS are more likely to gain weight in the abdominal area and more likely to find that standard dietary advice produces limited results without addressing the insulin dimension specifically.

Q4. What is PMOS, and is it different from PCOS?

A: PMOS stands for Polyendocrine Metabolic Ovarian Syndrome, and it is the new name for PCOS, proposed by an international specialist consensus in 2025. The condition is the same. The name change reflects a more accurate understanding of what drives it: PCOS suggested the problem was cysts on the ovaries, when in reality it is a systemic metabolic and hormonal disorder in which the ovaries are one affected site. PCOS remains the term in common use and in most search queries, but PMOS is increasingly the language of specialist clinical practice. At Menovivre we use both terms interchangeably.

Q5. Can I have PMOS if my periods are regular?

A: Yes. While irregular periods are one of the most common presentations of PMOS, some women with the condition have regular or near-regular cycles. Regular periods do not rule out androgen excess or insulin resistance. If you have other signs of PMOS, including persistent acne, excess hair growth, or difficulty losing weight, a hormonal assessment is worthwhile regardless of your cycle regularity.

Q6. How is PMOS diagnosed?

A: Diagnosis requires meeting at least two of three Rotterdam criteria: irregular or absent ovulation, elevated androgens on blood test or clinical signs such as acne or excess hair growth, and polycystic-appearing ovaries on ultrasound. A proper assessment also includes thyroid function, prolactin, and a metabolic panel covering fasting insulin and glucose. A diagnosis based on ultrasound alone, without hormonal investigation, is incomplete.

Q7. Does PMOS affect mental health?

A: Yes, significantly. Depression and anxiety are present in up to 60 per cent of women with PMOS, a rate three to eight times higher than in women without the condition. These are not simply a response to living with a difficult diagnosis. They are partly driven by the hormonal and metabolic features of the condition itself, including elevated androgens, insulin resistance, and disrupted sleep. Mental health support is a legitimate part of PMOS management, not an afterthought.

Q8. Do I need a referral to be assessed at Menovivre?

A: No. You can request an appointment directly without a GP referral. Our clinical team will take a full history, run appropriate investigations, and give you a clear clinical picture.

Dr. Aarti Javeri-Mehta

Physician – Specialist – Internal Medicine

Member of the Royal College of Physicians (UK) with over a decade of experience in metabolic health, insulin resistance, and menopause management. A member of the World Health Organization’s global network promoting education and innovation in preventive and lifestyle medicine.